Involving stemness factors to improve CAR T-cell-based cancer immunotherapy-Reference-Cited by-同舟云学术

Involving stemness factors to improve CAR T-cell-based cancer immunotherapy

Published:2023-10-01 Issue:11 Volume:40 Page:
ISSN:1559-131X
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Noraldeen Sara Abdalrazzaq M.,Rasulova Irodakhon,Lalitha Repudi,Hussin Farah,Alsaab Hashem O.,Alawadi Ahmed Hussien,Alsaalamy Ali,Sayyid Nidhal Hassan,Alkhafaji Adnan Taan,Mustafa Yasser Fakri,Shayan Sepideh Karkon^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12032-023-02191-7.pdf

Reference64 articles.

1. Arumugam V, Bluemn T, Wesley E, Schmidt AM, Kambayashi T, Malarkannan S, et al. TCR signaling intensity controls CD8+ T cell responsiveness to TGF-β. J Leukoc Biol. 2015;98(5):703–12.

2. June CH, O’Connor RS, Kawalekar OU, Ghassemi S, Milone MC. CAR T cell immunotherapy for human cancer. Science. 2018;359(6382):1361–5.

3. Chmielewski M, Hombach AA, Abken H. Of CAR s and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma. Immunol Rev. 2014;257(1):83–90.

4. D’Aloia MM, Zizzari IG, Sacchetti B, Pierelli L, Alimandi M. CAR-T cells: the long and winding road to solid tumors. Cell Death Dis. 2018;9(3):282.

5. Zhang Y, He L, Sadagopan A, Ma T, Dotti G, Wang Y, et al. Targeting radiation-resistant prostate cancer stem cells by B7–H3 CAR T cells. Mol Cancer Ther. 2021;20(3):577–88.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improvement of current immunotherapies with engineered oncolytic viruses that target cancer stem cells;Cell Biochemistry and Function;2024-06

2. The Role of Oxidative Stress in the Occurrence of Neurological Diseases and Cancer;Clinical Cancer Investigation Journal;2024

3. Broadening the horizon: potential applications of CAR-T cells beyond current indications;Frontiers in Immunology;2023-11-27